期刊簡介 | |||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
期刊名稱 | Nutrition Clinique et Metabolisme LetPub Score 4.7
50 ratings
Rate
Reputation 5.9 Influence 3.3 Speed 7.0 | ||||||||||||||||||||||||
期刊簡稱 | NUTR CLIN METAB | ||||||||||||||||||||||||
ISSN | 0985-0562 | ||||||||||||||||||||||||
E-ISSN | 1768-3092 | ||||||||||||||||||||||||
h-index | 13 | ||||||||||||||||||||||||
CiteScore |
| ||||||||||||||||||||||||
自引率 (2023-2024) | 20.00%自引率趨勢 | ||||||||||||||||||||||||
掲載範囲 |
| ||||||||||||||||||||||||
官方網站 | http://www.journals.elsevier.com/nutrition-clinique-et-metabolisme/ | ||||||||||||||||||||||||
在線稿件提交 | https://www.editorialmanager.com/NUTCLI | ||||||||||||||||||||||||
開放訪問 | No | ||||||||||||||||||||||||
出版商 | Elsevier Masson | ||||||||||||||||||||||||
主題領域 | 医学 | ||||||||||||||||||||||||
出版國/地區 | FRANCE | ||||||||||||||||||||||||
發行頻率 | 四半期刊行 | ||||||||||||||||||||||||
創刊年 | 1987 | ||||||||||||||||||||||||
每年文章數 | 45每年文章數趨勢 | ||||||||||||||||||||||||
黃金OA百分比 | 14.04% | ||||||||||||||||||||||||
Web of Science 四分位 ( 2023-2024) | WOS Quartile: Q4
| ||||||||||||||||||||||||
索引 (SCI or SCIE) | Science Citation Index Expanded | ||||||||||||||||||||||||
鏈接到PubMed Central (PMC) | https://www.ncbi.nlm.nih.gov/nlmcatalog?term=0985-0562%5BISSN%5D | ||||||||||||||||||||||||
平均審稿時間 * | 來自出版商的數據: 來自作者的數據: >12 Week(s), or Invited contributions | ||||||||||||||||||||||||
競爭力 * | 來自作者的數據: Easy | ||||||||||||||||||||||||
參考鏈接 |
| ||||||||||||||||||||||||
*所有的審稿過程指標,如接受率和審稿速度,僅限於用戶提交的稿件。因此,這些指標可能無法準確反映期刊的競爭力或速度。 |
|
|
首頁 上一頁 1 下一頁 末頁 (頁 | |
[Nutrition Clinique et Metabolisme] 的評論 | 撰寫評論 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 22:59:40 評論於 If possible, please try to supplement the experiment. If it is really not possible, then carefully consider reasons for defense, but a humble and cautious tone is essential. After all, even major revisions have a certain rejection rate(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 维尔娜菲茨杰拉德 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-30 19:49:57 評論於 When responding to the comments of the reviewers, all questions must be answered one by one without any omissions; try to meet the demand for additional experiments as suggested in the comments, and if it cannot be met, provide a reasonable explanation as to why it cannot be done; citations recommended by the reviewers must be used and discussed thoroughly; when submitting a revised manuscript, make sure to check the areas corrected in the initial draft. If you agree with the modifications suggested by the editor, simply accept the changes. If you disagree, write down your reasons below the comments and provide feedback to the editor. In case of disagreement, negotiations can be conducted(0) 讚! | 维尔娜菲茨杰拉德 |
作者: 上清雨真 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-28 19:57:51 評論於 What is the difference between responding to reviewer's comments and responding to editor's comments?(0) 讚! | 上清雨真 |
作者: Oswald Edie 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2021-12-26 23:56:26 評論於 The reviewer requested me to conduct additional experiments, but my samples have run out. The experiment has already ended. Will my paper be rejected if I just state that my samples are used up?(0) 讚! | Oswald Edie |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2017-07-14 20:56:11 評論於 As long as we can maintain the SCI journals, it will be fine. If the school starts calculating based on CiteScore in the future, we wouldn't have to worry. On one hand, CiteScore includes a wider range of journals, so this journal will definitely be included; on the other hand, it benefits smaller journals. The difference is not that significant for everyone. I hope the school adopts CiteScore(0) 讚! | 凌霄高洁 |
作者: 凌霄高洁 領域: 医学 審稿時間: 0.0 month(s) 結果: 待定&不明 撰寫評論 |
2011-06-29 08:23:02 評論於 Focus of research: Metabolism(0) 讚! | 凌霄高洁 |
首頁 上一頁 1 下一頁 末頁 (頁 |
Contact us